Ivana Lazich

发表

Prediction and management of hyperkalemia across the spectrum of chronic kidney disease.

G. Bakris, I. Lazich, Ivana Lazich, 2014, Seminars in nephrology.

The spectrum of albuminuria as a predictor of cardiorenal outcomes

G. Bakris, I. Lazich, Ivana Lazich, 2011 .

Effects of combining simvastatin with rosiglitazone on inflammation, oxidant stress and ambulatory blood pressure in patients with the metabolic syndrome: the SIROCO study

G. Bakris, A. Patel, I. Lazich, 2012, Diabetes, obesity & metabolism.

Chapter 30 – Kidney Disease in Hypertension

G. Bakris, S. Udani, I. Lazich, 2013 .

Effects of Nebivolol on Aortic Compliance in Patients With Diabetes and Maximal Renin Angiotensin System Blockade: The EFFORT Study

G. Bakris, A. Briasoulis, I. Lazich, 2013, Journal of clinical hypertension.

Endothelin antagonism in patients with resistant hypertension and hypertension nephropathy.

G. Bakris, Ivana Lazich, 2011, Contributions to nephrology.

Morphometric and histological parameters in veins of diabetic patients undergoing brachiocephalic fistula placement

I. Lazich, S. Watson, A. Chang, 2015, Hemodialysis international. International Symposium on Home Hemodialysis.

Epidemiology of hypertensive kidney disease

G. Bakris, S. Udani, I. Lazich, 2011, Nature Reviews Nephrology.

Blood pressure, hypertension, RAAS blockade, and drug therapy in diabetic kidney disease.

G. Bakris, I. Lazich, H. Yamout, 2014, Advances in chronic kidney disease.

Initial combination antihypertensives: let's ACCELERATE

G. Bakris, I. Lazich, Ivana Lazich, 2011, The Lancet.

Antihypertensive Therapy and New-Onset Diabetes

G. Bakris, I. Lazich, Ivana Lazich, 2012 .

Newer renin–angiotensin–aldosterone system blocker combinations: is there an advantage?

G. Bakris, Ivana Lazich, 2011, Current opinion in nephrology and hypertension.